In the present study, the ferroptosis-related gene SLC1A5 was identified as a potential prognostic biomarker for STAD, its upstream molecule miR-137 was explored, and the correlation between SLC1A5 and tumor-infiltrating immune cells and immune checkpoints in STAD was investigated. This evidence concerns the gene SLC1A5 and neoplasm.